Gestational Diabetes in Central Asia: Prevalence and Management

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02436551

Acronym

GESDICA

Enrollment

3200

Registered

2015-05-07

Start date

2015-09-30

Completion date

2018-07-31

Last updated

2019-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus

Brief summary

Evaluate prevalence and management of gestational diabetes in Tajikistan in two different settings (one rural and one urban).

Interventions

OTHERObservation

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 55 Years

Healthy volunteers

Yes

Inclusion criteria

* pregnancy

Exclusion criteria

* known diabetes mellitus

Design outcomes

Primary

Measure	Time frame
prevalence of gestational diabetes	1 year

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026